Detalles de la búsqueda
1.
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data.
Diabetes Obes Metab
; 25(6): 1723-1730, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810874
2.
Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial.
Europace
; 25(3): 845-854, 2023 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36758013
3.
Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.
Diabetes Obes Metab
; 23(8): 1892-1901, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914401
4.
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trials.
Prim Care Diabetes
; 17(4): 379-385, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37142540
5.
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database.
Diabetes Ther
; 14(2): 401-413, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596946
6.
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis.
Diabetes Ther
; 14(4): 639-652, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787044
7.
Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants.
Diabetes Res Clin Pract
; 190: 110012, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863553
8.
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies.
J Diabetes Complications
; 36(7): 108227, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717354
9.
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis.
Diabetes Ther
; 13(1): 57-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784005
10.
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.
Eur J Prev Cardiol
; 28(17): 1864-1872, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33624041
11.
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis.
Diabetes Ther
; 12(4): 1073-1097, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650085
12.
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis.
Diabetes Ther
; 12(4): 1159-1174, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751403
13.
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project.
BMJ Open
; 10(4): e033659, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32350009
Resultados
1 -
13
de 13
1
Próxima >
>>